RxDoctor Payments Data

Syeeda Alam, DO

Family Medicine · San Antonio, TXNPI 1144617564

Payments from drug & device makers

$642in general payments, 2019–2025

Across 33 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$195
  • Lilly USA, LLC$186
  • Otsuka America Pharmaceutical, Inc.$87
  • Boehringer Ingelheim$56
  • Amgen$39
  • Genentech USA, Inc.$39
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$642100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$642 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$13,016
Medicare patients
36
Services billed
150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide25$33,436
FarxigaDapagliflozin Propanediol27$27,772
OzempicSemaglutide14$27,579
KerendiaFinerenone11$7,130
Rosuvastatin Calcium26$348
Omeprazole30$323
Atorvastatin Calcium49$291
Levothyroxine Sodium25$287
Lisinopril42$270
Metoprolol Succinate20$253
Losartan Potassium37$237
Montelukast Sodium18$104
Metformin Hcl15$92
Pantoprazole Sodium14$90
Amlodipine Besylate21$56

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$186$33,43625 claims
AstraZenecaFarxiga$195$27,77227 claims
Novo NordiskOzempic$12$27,57914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,760 family medicine providers in Texas.

Other family medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →